[TEVA] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
11-Feb-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 14.00%
YoY- 27.80%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 4,295,000 5,065,000 5,630,000 4,810,000 4,982,000 5,001,000 4,901,000 -2.17%
PBT -84,000 1,254,000 688,000 867,000 557,000 891,000 699,000 -
Tax 9,000 46,000 54,000 228,000 104,000 143,000 53,000 -25.57%
NP -105,000 1,055,000 580,000 570,000 446,000 744,000 630,000 -
Tax Rate - -3.67% -7.85% -26.30% -18.67% -16.05% -7.58% -
Total Cost 4,400,000 4,010,000 5,050,000 4,240,000 4,536,000 4,257,000 4,271,000 0.49%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -2.44 20.83 10.30 11.85 8.95 14.88 12.85 -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -0.10 1.04 0.57 0.62 0.52 0.88 0.74 -
EPS Diluted -0.10 1.03 0.57 0.62 0.52 0.87 0.74 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.